Azuma M, Yssel H, Phillips J H, Spits H, Lanier L L
DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304.
J Exp Med. 1993 Mar 1;177(3):845-50. doi: 10.1084/jem.177.3.845.
B7/BB1 is a membrane differentiation antigen expressed on activated B cells, macrophages, and dendritic cells that binds to a counter-receptor, CD28, expressed on T lymphocytes and thymocytes. Interaction between CD28 and B7 results in potent costimulation of T cell activation initiated via the CD3/T cell receptor complex. We now report that B7 is also expressed on activated human peripheral blood T cells, CD4 T cell clones, CD8 T cell clones, and natural killer cell clones. B7 appears relatively late after T cell activation, can be detected on both CD4 and CD8 T cell subsets, and is present on antigen-specific, major histocompatibility complex-restricted CD4 and CD8 T cell clones. Expression of B7 on activated T cells was confirmed by immunoprecipitation from 125I-labeled activated T cells and by detection of B7 transcripts. A B7+ CD4+ T cell clone was able to stimulate a primary allogeneic mixed lymphocyte response using small, resting peripheral blood T cells as responders. The alloantigen-induced proliferative response and cytokine production was partially inhibited by anti-B7 monoclonal antibody. Since activated T cells can coexpress both CD28 and its counter-receptor, B7, this suggests that activated T cells may be capable of autocrine costimulation via the CD28 activation pathway.
B7/BB1是一种膜分化抗原,表达于活化的B细胞、巨噬细胞和树突状细胞上,它能与表达于T淋巴细胞和胸腺细胞上的配对受体CD28结合。CD28与B7之间的相互作用会通过CD3/T细胞受体复合物对T细胞活化产生强效共刺激。我们现在报告,B7也表达于活化的人外周血T细胞、CD4 T细胞克隆、CD8 T细胞克隆和自然杀伤细胞克隆上。B7在T细胞活化后出现得相对较晚,在CD4和CD8 T细胞亚群上均能检测到,并且存在于抗原特异性、主要组织相容性复合体限制的CD4和CD8 T细胞克隆上。通过对125I标记的活化T细胞进行免疫沉淀以及检测B7转录本,证实了活化T细胞上B7的表达。一个B7 + CD4 + T细胞克隆能够以静息的外周血小T细胞作为应答细胞来刺激原发性同种异体混合淋巴细胞反应。抗B7单克隆抗体可部分抑制同种异体抗原诱导的增殖反应和细胞因子产生。由于活化的T细胞能够同时共表达CD28及其配对受体B7,这表明活化的T细胞可能能够通过CD28活化途径进行自分泌共刺激。